Keywords
BF , CM, SEM, MVV , ML V , UL V
1. Introduction
A liposome is an artificially synthesized, self-assembled lipid v esicle composed of
a single bila yer or multiple concentri c bilay ers enclosing an aqueous core. Alec B angham
first introduced the field of liposomology and char acteri zed liposom e structure in the
mid-1960s. Since then, liposomes ha ve been extensi vely studied as one of the simplest
biomimetic sy st ems, resembling miniature cells without the complexities of nuclei or
cytoplasm (Sessa and W eissmann, 1968; Bangham et al., 1974; A dler and Schiemann,
1985; Bibi et al ., 2011; Aranda-Lar a et al., 2020; Andra et al. , 2022) .
T h e s i z e o f l i p o s o m e s r a n g e s f r o m ~ 2 0 n m t o s e v e r a l µ m , w h i l e t h e l i p i d b i l a y e r
thickness is typically 3–5 nm (Liu et al., 2022). Phosphatid ylcholine (PC) lipids
constitute ~40–50% of cell membranes (van der V een et al., 2017). In this study ,
dim yristoylphosphatidylcholine (DMPC), a commonly used lipid with a low main phase
transition temperature (T c ≈ 23 °C), is employed for liposome pr epar ation (Drabik et al.,
2020). Based on lamellarity , liposomes are classified as unilamellar vesicles (UL V s),
m ultilam ellar vesicles (M L V s), and multivesicular vesic les (M VV s) ( Giuliano et al., 2021).
UL V s ma y be further categorized as SUV s ( 1 µ m ) , a l t h o u g h s u c h s i z e d i s t i n c t i o n s a r e n o t t h e f o c u s o f t h e p r e s e n t s t u d y ( N s a i r a t
et al., 2023 ).
Liposomes are widel y explor ed in drug deli v ery as they encapsulat e hydrophilic
drugs within the aqueous core and h ydrophobic drugs within the lipid bila y er , thereby
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
enhancing stability , biocompatibility , and membrane penetr ation (Gomez and
Hosseinidoust, 2020; Umbarkar et al., 2 021; Mehta et al., 2023). They interact with cells
through endocytosis, e xocytosis, and lipid exchange, and serv e as vaccine ad ju v ants and
targeted nanocarriers for proteins, nu cleic acids, imaging agents, and cancer
therapeutics (W ang et al., 2019; Zhang and Sun , 2021; Fult on and Najahi-Missaoui,
2023).
V arious macroscale methods—such as thin-film h yd ration, extrusion, re v erse
evaporation, ethanol injection, electroformation, freeze-drying, and double emulsion—
are widel y used for liposome pr eparation (Šturm and PoklarUlrih, 2021). How ever ,
these approaches provide limited control over v esicle size and morphology (Danaei et
al., 2018 ), whereas biological sy stems r equir e highl y d efined geometries for specialized
func tion (Choi et al., 2023). Moreover , precise control over c argo release remains a
critical ch allenge, as sy st emic use of liposomes is often limited by rapid clear ance,
instability , and unintended drug r elease (Na gayasu et al., 1999; Kim and Jeong, 2021).
The article is structured as follows. First, the methodology employed for
lipos ome preparation is descr ibed in detail. Next , the main res ults are presented,
including the influence of uniform lipid thin-film formation on v esicle morphology , the
o p t i m i z a t i o n o f r e h y d r a t i o n b u f f e r v o l u m e , a n d t h e c a l i b r a t i o n o f p u l s e d p r o b e
s o n i c a t i o n f o r t h e f o r m a t i o n o f d i s t i n c t l i p o s o m a l p h a s e s . F i n a l l y , t h e f i n d i n g s a r e
summarized, and a concluding perspecti ve is provided outlining ke y challenges and
pot ential future dir ections for ad vancing liposome-based systems.
2. Methods
2.1 Liposome Preparation by Thin-Film Hyd ration
Different methods can be employed to prepare various liposomal phases. In the
present study , the thin-film h ydration t echnique (Bangham method) was employed f or
lipid vesicle prepar ation. Dim yristoylphosphatidylcholine (DMPC) was select ed due to
its low main phase transition t emperatur e (T
c = 23 ° C) (Drabik et al., 2020) .
Lipids were dissol ved in chloroform, follow ed by solvent evapor ation to form a
thin lipid film. Th e dried film was h ydrated with HEPES buffer (Lu and Qi, 2021;
Lombardo and Kiselev , 2022) and mechanically agitat ed to gener ate multivesicular
vesicles (MVV s). Subsequent probe sonication was performed to downsize MVV s into
multilamellar vesicles (ML V s) and u nilamellar v esicles (UL V s).
V esicle morphology and phase identification wer e carried out using bright-field
microscopy (BF), confocal microscopy (CM), and scanning electron microscopy (SEM)
(Fig. S1 in S1 of Supplementary Information (SI)) (R obson et al., 2018). These imaging
techniques enabled quantification of vesi cle number , size distribution, lamellarity , and
structur al characteristics (Lujan et al ., 2019).
2.2 Pr eparation of Lipid Thin Film: Influence of Film Uniformity on V esicle Morphology
Thin lipid films w er e pr epared by either air drying or rotary e vaporation to
evaluate their effect iv eness in producing uniform films.
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
F or film preparation, 10 mg of DMPC was d issol v ed in 1 mL chloroform t o ensure
complet e solubilization. When fluorescence microscop y w as perf ormed, 18:1 Liss Rhod
PE w as added at a concentration of 1 µM during this st ep (Shohda et al., 2015). Other
lipid-compatible fluorescent dyes wer e selected based on spectral compatibility and
lipid composition. Glassw are cleaning procedur es and detailed air-drying protocols are
provided in S2 and S3 of SI, respecti vel y (Has and Sunthar , 2020).
2.2.1 Air-Drying Method
Thin films w ere f ormed by e vaporating chloroform under ambient conditions in
different containers to ev aluate the effect of geometry on film uniformity and vesi cle
morphology . Air drying in an Eppendorf tube led to uneven sol vent e vaporation due to
its cylindrical shape, sharp edges, and limited surface ar ea, causing lipid accumulation at
the base and formation of thicker r egions or sediment-like aggr egates, which produced
heterogeneous vesicle size distribution upon hydr ation (Fig. S2(a) in SI). In contrast, a
conca v e w atch glass pro vided a larger evaporation surface and yield ed comparati vel y
more unif orm vesicle distribution after hydration, despit e slightly thicker lipid
deposition t oward the center (Fig. S2(b) in SI). Overall, container geometry influenced
evaporation rat e, film thickness, and lipid distribution, and air drying frequently
resulted in incomplete solvent r emoval and film heterogeneity (Hadian et al ., 2014).
2.2.2 R otary E vapor ation Method
F or rotary ev aporation, the lipid–ch loroform solution was transferred to a round-
bottom flask and e vaporated under r educed pressu re at temperatures above T
c u s i n g a
two-step protocol. Initially , sol vent removal w as performed at 41 °C and 480 mbar with
rotation at 60–70 rpm for 15 min t o form a thin lipid film. Subsequently , the
temperature was lowered to 36 °C and the pressur e r educed t o 56 mbar while
maintaining 70 rpm for an additional 10 min t o enhance drying under higher vacuum
(Zhu et al., 2013). Alternati vely , residual chloroform was eliminated by brief vacuum
desiccation (650 mmHg for 1 min) followed by overnight vacuum. Controlled rotation
ensur ed uniform lipid spr eading along th e flask surface, and reduced pressure
promot ed efficient sol vent removal. Upon reh ydration, these films produced vesicles
with homogeneous spatial di stribution and narrow size dispersion (Fig. S2(c)),
outperf orming air-dried films (Fig. S2(a), (b)) by yielding thinner , more uniform films
with minimal residual solv ent contamination, ther eby providing superior control over
film quality and v esicle homogeneity .
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
3. Results and Discussion:
3. 1. O p t i m i za t i o n of Re h yd r a t i on B uf f e r V o l um e
T he li pid fi lm s pr ep a red b y a i r d ry ing or r otary e v apor ati on w er e h y d rat ed i n aqueous
bu ff er , su ch as p h osphat e- buff er ed sali ne or HEP ES bu ff er ( L u and Qi , 20 21; L ombar do
and K i s ele v , 20 2 2) . In t hi s stu d y , HEPE S b uff er , a wi d el y used bi ologi c al buf f er th at
closel y mi m ic s p h y s i ologi cal conditi ons (Nadd af D ezful i et al., 201 4 ) , w as em plo y e d
(composi t i on det a i led i n S4, SI). Aft er r e h y dr ati on, s amp les w er e i n cu b at ed at 37 °C f or
1 h a n d vo r texe d fo r 1 m i n pr i o r to br i g ht - f i e l d i m a g i ng . Di r e c t vi s ua li z a t i o n wi th
cont rol led di l uti on w as adopt ed t o a v o i d spat ial h et er ogenei t y as s o c ia t ed wi t h m a n ual
s m e a r in g a n d t o e n s u r e r e p r o d u c ib l e v e s ic l e d is t r ib u t io n .
T o c a l i b r a t e v e s i c l e d e n s i t y a n d m i n i m i z e o v e r l a p , t h e r e h y d r a t i o n v o l u m e w a s
s y s t e m a t i c a l l y v a r i e d ( 0 . 5 , 2 , 3 , 3 . 5 , 4 , a n d 5 m L f o r 1 0 m g l i p i d ) . V e s i c l e a r e a s w e r e
e xtr act ed fr om m i cros cop y i m a g es (F i g. 1 ( a )), and t he p r obabi li t y di str ibution, P( A ), w as
d e t e r m i n e d ( F i g . 1 ( b ) ) , a p p r o x i m a t i n g v e s i c l e s a s c i r c u l a r ( A = π r ² ) . A c u t o f f a r e a ( A
c =
50 µ m ² ; r c ≈ 4 µ m ) w a s u s e d t o d i s t i n g u i s h o v e r l a p p i n g ( A > A c ) fr om non-o verlapp i ng
( A ≤ A c ) v es icles. T he o v e rlap fr a cti on decr eas ed w i t h i n cr e asi n g v olu me and plat eaue d
a t 4 m L (F ig . 1 ( c ) ) , w h e r e a s v e s i cl e c o u n t s in it ia l l y i n c r e a s e d ( 2 m L ) d u e t o r e d u c e d
o v e rlap and subs equent l y d ecl i ned at hi g he r v olum es be cau s e of di lu tion ( Fi g. 1 ( d ) ) . A t
5 mL, v es i c le d ens i ty bec ame i nsu ffi cien t f or rel i able i m agi ng . A cc or di n gl y , 4 m L w a s
i d enti f ied as th e opt i mal r eh y d r ati o n v ol ume, balanc i ng h igh v e s i c le co un t wi t h mi n i mal
o v e rlap f or r obust bri ght- fi eld visua lizat i on and qu anti t ati v e anal y sis (Zhu et al., 2013).
F i g u r e 1 : A f t e r r e h y d r a t i o n o f a 1 0 m g D M P C t h i n f i l m w i t h b u f f e r ( 0 . 5 – 5 m L) , s a m p l e s w e r e i n c u b a t e d a t 3 7 ° C f o r 1 h ,
v or t e x e d f o r 1 m in , a n d i m a ge d by b r i gh t - fi e ld m ic r os c op y . ( a ) V e s i c l e d i s t r i bu t i on s a t d i f f e ren t b u ff e r v ol um e s . ( b)
Pro bability d is tri b ut io n of ves i c l e area, P (A). A cutoff area (A
c = 5 0 µ m ²) d i s tingui s h e s overlapped (A > A c ) from no n -
o v e r la pp e d ( A < A c ) v esicles (grey ) . (c) Pe rcent ag e of ove rl app ed and non-o v erla pp e d ve sicles ve rsu s bu ff e r v o lume, sho w ing
re d uced o v erla p wi th in cre a s i ng v olu m e a nd sa tu r ation at 4 mL. (d) T o t al v esicle co u n t a s a fun c t i o n of bu ff e r v o lume. Error
ba rs deno t e s tand ard deviation fro m 20 imag e s.
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
F i gure 2: Schem a tic repres e n t atio n o f th e p u l s ed prob e sonic a t ion, s h ow i ng amp li t ud e , A w ith n u mber of cycle s. (a) shows
the pulse d probe sonica ti o n c a rried o ut f o r t ot al 9 cy cles (1 0 se co nd ON an d 50 sec o nd OF F p e r cy cle ) f or 30% a m plit u de,
whi l e (b) t h e same f or tot al 37 cyc l e s ( 5 second ON and 55 s econd OF F p e r cycle ) f or 2 0 % amp l it ud e.
3 . 2 . Optimi z ati on of Pr obe Soni catio n t o Obtai n Di ff er ent l i posomal Ph a s es
A f t er r eh y d r ati on an d v ort e xi ng (1 m i n), MVV s w er e f ormed (Fi g. 1 ( a ); Fig. S4( a) in S7,
SI ) . V esicle downs i z i ng w as perf o rmed t o ob t ai n ML V s and UL V s. Among a v ai l able
m ethods—ho mogeni zation, sonicat i o n, and e x t r u s ion (Lombar do and K i sele v , 2022 )—
soni cat i on i s p r ef e rr ed f or eff icient s ize contr ol vi a acou stic d i s ruption of li p i d
aggr eg at es ( M au luc ci et al., 2 005 ) . B ath s on i cat i on (90 min; S5, SI ) pr ed omi nan tl y
yi el d ed ML V s w i th r e si du al MVV s (Fi g. S3 , S5, SI), consist ent wi th li mit ati ons i n pow er
and freq u ency c o ntr ol ( d e F r e i tas et al., 201 9; Morr isse y , 20 01 ).
P robe sonicati o n (130 W , 20 kHz, 6 m m prob e) w as the r ef or e em plo y ed . C onti n uous
soni cat i on at 30 % am pli tu de f or 3 0 s (Sha rma et al., 202 3 ; Zen g et al . , 2 023) i n duc ed
h e at i ng and m etalli c c on tami n ati on (F i g. S4(b) i n S7, SI ) . I c e- bath co oli ng ( Lo mbar do
and Ki sel e v , 2022 ) ris k ed ph as e perturbati o n d ue t o thermal c y cling. T o min i mi z e
t her m al and cont ami nat i on ef f ec t s, p ulsed pr ot ocols w er e opti m i zed . A t 3 0% ampli t ude
(10 s ON / 5 0 s O FF) , UL V s appe ar ed at net O N-t i mes ≥6 0 s and w er e e vident at 90 s
(Fi g . 2 (a); Fi g. S6 i n S9, SI) , thou gh h eati ng r emai n ed si gn i f i c ant .
A low er ampli t ude (2 0% ) wi t h 5 s O N / 55 s OFF w a s then s y st em ati c all y v aried ( 5– 1 85
s net ON-t i me; F i g. 2(b) ) . M L V s e merged at 90 s ( 18t h c y cl e) and U L V s at 160– 18 5 s
(32n d– 37t h c y c l es ). Th e ext ende d OFF pe r iod l i m i t ed h e ati ng an d pr obe e r osi on.
A ppr o xi mat el y 20 i mag es pe r c y c l e w er e anal yz ed us i ng a cu st om Pytho n w orkflow (S6 ;
Fig. S7 i n S9, SI). V esicle ar e a (A) and rad i us (R) w er e e xtr act ed a s sum i ng circ ular
geom etry (A = π R²; R = √(A/π ) ) . G a u s sian fi t s t o P( R ) e x c l ud i ng ra r e lon g-tai l e v ents
yi el d ed m ean r ad i i w ith e rr or ( Fig . 5c– d ) . The e v olu ti on of m ean r ad ius w i th ON-t i me
(Fi g . 5e ) clas si fied ph as e s a s M VV ( R > 4 µm), M L V ( R ≈ 1.5– 4 µm ) , and UL V ( R M L V > U L V , c o n s i s t e n t w i t h
r epr esen tativ e i mages ( Fi g. S4 i n S7, SI) .
C onfocal m i c roscop y (F i g. 4 (a – d) ; S1.2 i n SI) r e v eal ed lamell ar stru ctu re at 90 s (ML V
ph a s e) , whi le S E M a t 18 5 s ( F i g. 4 ( e– f ) ; S 1 . 3 i n S I ) sh o we d s phe r i c a l U L V s wi t h s l i g ht
m embr ane und ulati on . O v e r all, s o n i cati on am pli tu de and du ty c y cl e go v er n v esicle
m or p hology: hi gh er ampli t ude acc eler at es UL V f ormati o n b ut i ncrea ses t h ermal r i sk ,
w h er eas low- ampli t ude pu lsed ope r ati on en ables contr olled , c on tami n ati on- mi nimi zed
p rodu c t i on of d i sti nct l i p os o mal phase s ( S10 in SI) .
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
These findings show that sonication amplitude and duty cycle govern vesicle
morphology: high amplitude yields rapid UL V formation but risks thermal damage,
whereas low-amplitude pulsed sonication achieves the same outcome more safely over
longer times. Therefore, tuning sonication parameters enables controlled and reliable
production of the desired vesicle type ( S10 in SI) .
F i gure 3 : Chara ct e ri z a t ion of ve sicles. (a) Brig h t -field i m a ge a t a n ON-t i m e of 1 8 5 s ( 3 7t h c yc l e) duri ng p u lsed p r o be
soni c ati o n a t 2 0 % a m plitude. (b ) V esicle i den t i f ic ati o n usi n g a c u s t om Pytho n-b ased machi ne learni ng w o rkflo w (c ont o ur
det e ctio n). (c ) His t og ram of ves i c l e ra dii ( R ). (d) No rm a liz ed p robabili ty d is trib u t io n , P ( R ), fitt ed w ith a G a ussian f u nct ion
(e x clu di n g ra re long -t ai l e ve n ts) t o o b t ain the m ean ra di us wit h error . A ppr oximat ely 2 0 images ( ~40 0 0 ves i c l e s) were
an alyz e d per time poin t. (e ) E voluti o n of me a n ve s i cle ra dius wi th ON-time at 3 0 % and 2 0 % ampl i t ud e s, h ighl i g h t ing MVV
(gre e n ), M LV ( gray), and ULV (blue) p h a se s.
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
F i gure 4: C on f oc a l an d SEM chara ct e ri z a t ion of l iposomes . (a,b ) C o nf o c a l imag es a t t he 37th and 18t h c ycles o f pulsed
pro be son i c ati o n (20% a m p li tu de; 5 s ON / 55 s OF F). ( c , d) Three - dim e n sion al Z -s t a ck a nd m a g n ifi ed view (do tt ed squ are)
re v eali ng lamella r s truct ure in dic a t ive o f th e M LV p ha s e. (e) S EM imag e at th e 37th cy cle. ( f ) M a gni fied v i e w (b lack dott ed
squa re ) sho w i n g sp h e ri c a l ULV s wi th sli g h t m embran e un d u la tion.
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
4. Conclusion
A sy st emat ic an d optim iz ed w orkflow f or l iposome p rep ar ation i s establi s hed ,
int egrati ng thin -film f or m ation, contr olled d r y in g, cal ibr at ed r e h y dr at ion, v esi c l e
down s i zin g, and ad v an ced ima ge a nal y si s (F ig. S8 in SI). Cont ainer ge ometry m ark edl y
inf luenc es film uni f ormity and v esi cle m orphology: s h a r p- edg ed E ppend or f tu bes
pr oduce h et er ogeneous film s and br oad v esi c l e di stribu tions, w he re as cu rv ed w at ch
glas s es y ield com parat i v el y unif o rm f ilms; th e most hom ogeneous and com plet el y dr ied
film s ar e obtain ed b y ro tary e v apo r ati on at 41 °C and 4 80 mbar f or 15 min ( 60 –70 rpm),
f ollow ed b y 36 ° C an d 56 m bar f or 10 m in (70 rpm) and o v e rnig ht de s ic c at ion at 866 .6
mbar , w hil e ai r d ry ing oft en r esult s in s t i c k y , i n complet el y d ri ed f ilms. R eh y dr at ion i s
opt imized at 4 mL HEP ES buff er per 1 0 mg l ipid , min im iz ing v e si c le o v e rlap w hil e
main tainin g suff ic ien t conc ent rat ion; low er v olum es inc re ase o v e rlap , w her ea s h i gh er
v olum es r ed u ce v e si cle den sit y . F or MV V d ownsiz ing, b ath s o nic ation ( u p t o 90 mi n)
pr edomi nantl y yi elds ML V s withou t cont aminat ion b ut requ ir es p rolon ged pr oc es s in g.
In con tr as t, p rob e s on i c at ion enab l es r apid s iz e r ed uction; con tinuo us o perat ion at 3 0 %
ampl itude f or 30 s ind uces he atin g and m e t alli c con tamin ation. Pul sed soni cation at
30% ampl itude (10 s ON/5 0 s O FF , 9 c y cl es ) r ed uc es cont aminat ion bu t ret ains the rmal
eff ects, w her ea s fu r t he r o ptim iz a t ion t o 20% amplit ude (5 s ON /55 s OFF ) f or 37 cy cle s,
corr espond ing t o net O N tim es of 9 0 s an d 185 s, r epr odu c ib l y ge n e rat es ML V s and UL V s ,
r es p ect i v e l y , withou t det ectable he ati ng o r pr obe-der i v ed p arti cles ; r esid ual tit anium
fr agment s a r e r emo v ed b y cent r i fu g ation at 10 ,000 × g f or 3 mi n. F or SEM pr epar ation ,
r emo v al of e x c es s buf f er com ponent s , in c lu ding su cr ose, i s essent ial t o p re v ent c h arging
during gold sput t ering. Qu antit ati v e r obustn es s is enh an ced using a m achin e le arning –
based P ython image a n al y s i s w o r k f low . Collecti v el y , th e opt imiz ed pr ot ocol pr o vides a
r epro du cible, con taminat ion- mini m ized , and th er m all y cont rolled str at egy f or pr e ci s e
r egul ation o f liposome ph ase beh a v i or , v esicl e s i ze d istr ibuti on, and str uctur al int egrity .
5. Conflict of Interest:
Th e au thors de c l ar e that the r e ar e n o confl ic t s o f int er e st .
6. Acknowledgements:
A.P . a cknow ledg es th e s u pport un d er A nusandh an N at ional R e s e ar ch F ound ation
(ANRF), Dep ar t ment of Sci enc e and T ech nology , Go v ernmen t of India [ SER B-
SR G /2022 /00148 9] an d T .R. R ajag opalan r es ear ch fu nd, S A S TRA Uni v er s ity , In dia . A.R .,
S.S. and A .P . w ould lik e t o than k t o R ajan K .S. , R ajesh Y .B.R . D ., D ha k shinam oorth y S.,
Shank e r Jha, Sent hilk um ar R . , A r un ac h alam J., Aksh a y a J. and thei r lab m embers f o r th eir
support an d v alu able a ssistan ce.
7. References:
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
1. A d ler K . and Sc h i emann J. (1985 ) . C hara ct eri zatio n of lipo s om es b y scanni ng el ectr on
micr os c o p y and t he fr e eze- fr act ur e t ec h nique. Micr on and Mi c r o sc opic a A ct a . 1 6 ( 2) : 109 -
113 . h ttp s ://d o i.or g /10 .10 16/0 739 -6 260(85 )900 39-5 .
2. An dr a V . V .S. N .L. , P ammi S.V . N . , B hatr a ju L.V . K.P . and R udd a raj u L.K. (2 022) . A
Com preh ensi v e R e vi ew on N o v el L ipo s om al Met hodolo g i es , Comm ercial F or m ulation s ,
Clin ical T r ial s an d P at ents. BioNa noScie nce. 12 (1 ) :2 74-
291 .http s ://d oi .or g/ 1 0.1007 /s12 6 68- 022-0 0941 -x
.
3. Ar and a-La r a L . , M or ales-A vil a E., Lu na- Gut iér r e z M.A., Oli v é-Al v a r e z E. and Is aa c-Ol i v é K .
(2020) . R adio labeled liposom es and l ipopr ot ein s as lipid i c nan oparti cl es f or im a ging and
th erap y . C hemis t r y and Ph ysics of L ipid s .
230 :1049 34 .htt ps://doi .org/1 0.10 1 6/j. c h emph y slip .20 20.10 4 934
.
4. Ban gh amA . D ., Hill M . W ., an d Mil le r N .G.A ( 1 974 ). Pr epa rat ion an d Use of Liposom es a s
Mod els o f Bio logical Memb rane s. In:M ethod s i n memb rane b iolog y(Ed. K o r n , E . D .).
Springer , B os t on, MA, 68 pp.
5.
Bi bi S., Kau r R. , Henri k s en -L ace y M., Mc Neil S .E., W ilkhu J., Lattm ann E . , Christ ensen D . ,
Moh ammed A .R. and P e rri e Y . (201 1) . Mi cr os c o p y imaging of liposome s: F r om co v erslip s
to e nv i ro n m e nt a l S EM . In te rna tio nal Jo ur nal of Pharmac euti cs . 41 7(1- 2); 138- 15 0.
ht tps://doi.or g/10.1 0 16/j .ijp harm. 20 10.12.02 1 .
6. Cho i S., K ang B ., Y ang E., K im K . , K w ak M. K. , Chang P . - S. and Jung H .- S. ( 2 023 ). P r e cise
contr ol of liposome si z e u sing cha ra ct eri stic time d epen d s on sol v ent typ e and
mem bran e pr operti es . Sc i Rep. 13(1): 472 8 . h ttps://do i . org /10 . 1 038/s415 98-0 2 3-
318 95-z .
7. Dan ae i M., D eh gh ankhold M., A taei S., H asan zad eh D a v ar ani F ., J a v an m ard R. , D o khan i A . ,
Khor as ani S. and Mozaf a ri M . R . ( 2 0 18). Imp ac t of P ar t i c le Si ze and P o l y d i s p ersit y Inde x
on the Clin i cal A pplicatio ns of Lip i d ic N anoca r r ie r S y st em s . Pha rmac eutics . 1 0(2 ) : 57.
ht tps://doi.or g/10.3 3 90/ph arma ce uti c s10 02 005 7
.
8. de F r eitas C.F ., Calori I.R., T es sa r o A .L., C aetano W . an d H ioka N . (201 9 ). R apid f ormat ion
of Small Unilam ella r V esi cle s (S UV ) thr ou gh low- fr equ ency s on ic a t ion: A n inno v ati v e
appr oac h. Coll oids and Sur face s. B , Biointe r fac e s . 181 :8 37-
844 .http s ://d oi .or g/ 1 0.1016 /j. cols urfb.201 9.06. 027
.
9. Dr abi k D . , Chod a c zek G., Kr as zew sk i S . an d Lan gne r M. (202 0). Mec h anic al P roperti es
Det ermin at ion of D M PC, D PPC , DSP C, and HSPC Solid- O r d er ed B il a y ers. La ngmui r .
36(14) : 382 6-38 35. htt ps : //doi.o rg/1 0.1021 /acs.l angmu ir .0 c0047 5
.
10. F ult on M.D . and Naj ahi- Mi ss aoui W . (202 3). L ip osomes in C ancer T he r ap y: H o w D i d W e
Start and Wh er e A re W e Now . Int ernat io nal J o urnal of Molecular Sc i e nc e s . 24 ( 7 ) : 66 15.
ht tps://doi.or g/10.3 3 90/ ijms24 07 661 5
.
11. Gi uliano C.B. , C v jetan N. , A y ach e J. and W ald e P . ( 20 21) . Mul ti v esi c u la r V esi c l es:
Pr epa r ation and Ap pli catio n s . ChemS y st e msChem. 3(2 ) : e200 0049.
ht tps://doi.or g/10.1 0 02/ sy s t.202 0 0 0049
.
12. Gomez A.G. and Hosse ini doust Z . ( 202 0) . L iposom es f or A nti biotic Encapsul at ion and
D e li ver y . AC S I n fe c t D i s . 6( 5) : 896- 9 08. ht tps://doi .org /10.102 1/a csin f ecd is. 9 b0035 7
.
13. Hadi an Z., S aha ri M.A ., Moghi mi H.R. and B ar zeg a r M. (2 0 14 ) . F ormu lation,
cha r a c t er i z ati on and opt imiz ati on of lip os o mes con tainin g ei cos apent aenoi c and
d o c o s a h exae n o i c ac i ds ; a me t h o d o lo g y a p p ro ac h . Ir anian j ou r na l o f pharmac eutic al
re se a rc h . 13 (2 ):393- 404 .P MID: 252 37 335
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
14. Has C. and Sunt har P . (2019 ). A co m preh ensi v e r e v ie w on r ec ent pr ep ar ation t echn iqu es
of liposomes. Jour na l o f L ip os ome Re se a rc h . 30 ( 4 ):33 6- 365.
ht tps://doi.or g/10.1 0 80/089 82 10 4 . 2 019.16 68 010 .
15. K im E . - M. and Jeong H.- J. (2021 ). L ipo s om es : B iom edi cal A ppli cati ons. Chonnam Med J .
57(1) :27 –3 5. http s :/ /d oi.o r g/1 0 .40 68/cmj . 2 0 21.57. 1.2 7 .
16. Liu P ., C hen G ., and Zh an g J. ( 2022 ). A R e vi ew of Lip osomes as a Dr ug D el i v er y S y st em:
Curr ent Stat us of A ppr o v ed Pr oducts, R egul at o r y En vi ron ments, and F utu re
Pe rs p ec t i ves . Mo le cu les. 2 7( 4 ): 137 2. h ttp s ://d oi .or g /10 .3390 /m olecul es27041 37 2
.
17. Lom bard o D . and K isel ev M.A . ( 2 0 22). M et hods of L iposomes P rep ar atio n: F ormat ion
and Con tr ol F act o r s of V er sati l e Nanoc arri ers f or Biom ed ic al a n d N ano medi cin e
Ap plication . Pharma c eutics . 14(3):
543 .http s ://d oi .or g/ 1 0.3390 /p ha rm ac eu ti cs140 30 543
.
18. L u W . - L . a n d Q i X . - R . ( 2 0 2 1 ) . L i p o s o m e - B a s e d D r u g D e l i v e r y S y s t e m s . S p r i n g e r B e r l i n
Heid elbe rg. htt ps : //d oi.o r g/1 0 .100 7/9 78-3 -662 -493 20-5 .
19. Lujan H . , Griff in W .C., T aube J.H. and Sa y es C.M. ( 2 019 ). Syn the si s and c har ac t eriz ati on of
nano met er-siz ed li posomes f or en capsu lation and micr oR N A tr ansf e r t o breast c anc er
cells . In t er n ational Jou r nal of Nanomedi cin e. 14 :5 159 –
517 3.htt ps://doi .org /10.214 7 /IJN . S20333 0 .
20. Maul uc c i G . , D e Sp irit o M., A rco vi t o G ., B offi F ., Co ngiu Cast ellano A . and B rig anti G.
(2005) . P arti cle Si ze D istr ibuti on in D MP C V esicl es Soluti ons U n d er go i ng Diff er ent
Sonicat ion Tim es. B io phy s ica l Jo ur n a l. 8 8(5 ) : 3 545- 3550 .
ht tps://doi.or g/10.1 5 29/biop h y s j. 10 4.0488 76 .
21. Meht a M., B ui T .A., Y ang X ., Ak so y Y . , Go ld y s E .M. an d Deng W . (2 023 ) . Lip id -Ba sed
Nanoparti cle s f o r Drug /Gen e D e l i v e ry : An Ov e rvi ew of th e P r oductio n T e chniq ue s and
Diff icult i es Encou nt er ed in The ir Industrial D e v elop ment . AC S M a ter A u . 3(6 ) : 600 -619 .
ht tps://doi.or g/10.1 0 21/a cs m at er i als au . 3 c 0 0032
.
22. Mend ez R. an d B an e r je e S. ( 20 1 7) . Soni cation -Bas ed B as ic Pr ot ocol f o r L iposome
S ynt hes i s . Met hods in Mo lec ula r Bi ol ogy . 1609 :2 55-2 60. htt ps://doi.o r g/10.100 7 /978- 1-
493 9-69 96-8 _21 .
23. Morriss e y J.H. ( 200 1).Morri ss e y la b pr otocol f or pr epari ng pho s ph oli pid v esi c l es (S U V )
b y sonic atio n. Urbana , IL: Un i v er s it y of Illin ois at Urbana- Champai gn.
24.
Nadd af D e zfuli S. , Hu an Z., Molc J.M.C., Leeflang M.A ., Ch ang J. and Zhou J. ( 20 14 ) .
In f l u e n c e o f H E P E S b u f f e r o n t h e l o c a l p H a n d f o r m a t i o n o f s u r f a c e l a y e r d u r i n g i n v i t r o
degr adatio n t ests of magnesium in DMEM. P ro gr e ss in N atura l S c ie n ce . 24(5 ) .
ht tps://doi.or g/10.1 0 16/j .pnsc .201 4.08 .009
.
25. Nag a y asu A., U c h i y ama K. and K i w ada H. (1999 ) . T he si ze of liposomes: a f act or w h ic h
aff ects thei r ta r g et ing effic ien cy t o t um ors an d t her ap euti c a ct i v i ty of l iposomal
ant itum or d r ugs. Advan c ed Dr ug Deli v er y R e vi ews . 40 ( 1) : 7 5- 8 7 .
ht tps://doi.or g/10.1 0 16/S016 9-40 9X(99)00 041 -1
.
26. Nsai r at H ., AlSh aer W ., Odeh F ., E s s a wi E., Kh at er D .,AlB a w ab A., El-T a n a ni M., A wid i A. and
Mub arak M.S. ( 2 023 ). R ec ent ad v a nces in us ing l iposomes f or d el i v ery of n ucle ic a cid-
based t he rap euti cs. OpenNano . 1 1: 10 0132 .
ht tps://doi.or g/10.1 0 16/j .onano.20 23.100 132
.
27. R o b s o n A . - L . , D a s t o o r P . C . , F l y n n J . , P a l m e r W . , M a r t i n A . , S m i t h D . W . , W o l d u A . a n d H u a S .
(2018) . A d v antage s an d L i mitat ions of Cu rr ent Imagin g T ec hniq ue s f or C har act er i zing
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint
Lip os om e Morph ology . F r ont ie rs i n Ph armac olo gy . 9 :80.
ht tps://doi.or g/10.3 3 89/fph ar .201 8.00 080 .
28. S e s s a G . a n d W ei s s m a n n G . ( 1 9 68) . Ph o s p h o l ip i d s phe r u l e s ( li p o s o me s ) a s a mo d e l f o r
biol ogical m embr ane s. J o ur na l o f L ip id Re se ar ch. 9 ( 3 ): 31 0-31 8 . P MID : 5646 182.
29. Sharma K., Nils u w an K ., Ma L. and B enjak ul S. (20 23 ). Ef f ec t of Lip oso mal Encaps ulat ion
and Ultr asoni cation on Debit t er i n g o f P rot ein H y drol y s at e and Pl ast ei n from S al mon
F r ame. F ood s. 12( 4): 761. ht tps://d oi.org/1 0.33 90 /f oods12 0407 61 .
30. Shoh da K ., T ak aha sh i K. and Su y am a A. (20 15) . A m ethod of gentle h y d rat ion t o pr e p ar e
oil- fr ee g i a n t uni lamell ar v esi cle s that c an con fine en zymat i c r ea ction s . Bi ochemi st ry and
Bi oph y si c s R ep o rt s. 3 :76 -82. ht tps:/ /doi.org /10.101 6/j.bbr ep .2015 . 0 7. 005 .
31. Štu r m L. and P oklar U lr ih N. (20 21 ). B asi c M ethod s f or Pr epar ation of Liposom es and
Stu d ying T he ir Int er actions wi t h Diff er ent C ompou nds, with t he E mphas is on
Po ly ph e n o l s . In te rn ational J ou rnal of Mol ecula r Sci enc e s . 22 ( 12 ) : 654 7.
ht tps://doi.or g/10.3 3 90/ ijms22 12 654 7
.
32. Umbar kar M., T ha ka re S ., Su rus he T ., Gir i A . and Cho pade V . ( 2 0 21) . F ormul ation and
E v a l u a t i o n o f L i p o s o m e b y T h i n F i l m H y d r a t i o n M e t h o d . Jo u r na l of Drug Deli v e r y and
Ther apeuti cs . 11 ( 1) : 7 2- 7 6 . ht tps:// doi.org/1 0.22 270 /jdd t .v11 i1 . 4 6 77
.
33. v an d er V een J.N ., K en nell y J. P ., W an S., V ance J.E . , V an c e D .E. and Ja c o bs R.L. ( 2 017 ). The
cri tic al ro le of pho s ph atid y l choli ne and ph os p hatid y l e t hanolam ine met abolism in h e alth
and dis ease. Bioch imic a et Bioph ys i c a A ct a (BBA) – Biomembr an es. 18 59(9): 1 558- 1572 .
ht tps://doi.or g/10.1 0 16/j .bbamem .2017.04 . 0 06
.
34. W ang N ., Chen M. an d W ang T . (20 19 ) . L iposomes used as a v ac cine adju v a n t-d eli v e r y
sy s t em: F rom basics t o clini cal immu nization . Jour nal of Contr o lle d R e l e as e. 30 3 : 1 30-
150 . h ttp s ://d o i.or g /10 .10 16/j .jcon r el.201 9 .04.0 25
.
35. Zeng H . , G uo S., R e n X ., W u Z. , L iu S. and Y a o X. (2023 ) . Cu rr ent Str at egi es f or Ex osome
Cargo L oad ing an d T a rgeting D el i v ery . Ce l ls .
12(10) :141 6 .htt ps://doi .org/1 0.33 90 /cells12 1014 1 6
.
36. Zhan g G. an d Sun J. (202 1). L ip id i n Ch ips: A Brief R e v ie w o f Lip os o mes F ormation b y
Micr oflui d ic s . In t ernat i onal J our nal of N a nomedi cine . 1 6 : 7 391- 7416 .
h tt p s : / / d o i . o rg / 1 0 . 214 7 /i j n . s 3 3163 9
.
37. Zhu T .F ., B udin I. and Szos t ak J . W . (2013 ) . Pr ep a rat ion of F atty A cid or Phospho lip id
V esicl es b y T hin- film R eh y d r a t ion. In: Method s in Enz ymology , A cadem ic P r es s, 2 67-2 74.
.CC-BY 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted May 13, 2026. ; https://doi.org/10.64898/2026.05.09.724055doi: bioRxiv preprint